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Coronary CT angiography is widely recognised as a reliable 
imaging modality for the diagnosis of coronary artery 
disease. Coronary CT angiography not only provides 
excellent visualisation of anatomical changes in the 
coronary artery with high diagnostic value in the detection 
of lumen stenosis or occlusion, but also offers quantitative 
characterisation of coronary plaque components. 
Furthermore, coronary CT angiography allows myocardial 
perfusion imaging with diagnostic value comparable to the 
reference standard method. Coronary CT angiography-
derived haemodynamic analysis has the potential to 
evaluate functional significance of coronary lesions. This 
review article aims to provide an overview of clinical 
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Implications for Practice:  
1. What is known about this subject?  
Coronary CT angiography is a widely available imaging 
technique for the diagnosis of coronary artery disease. 
2. What new information is offered in this case study? 
This review provides an overview of current status of 
coronary CT angiography with a focus on the diagnostic 
value, quantitative assessment of coronary plaques as well 
as its roles in patient management and treatment strategy 
guidance. 
 
3. What are the implications for research, policy, or 
practice?  
Coronary CT angiography is developing rapidly over the last 
decades and its role in coronary artery disease continues to 
evolve. A good understanding of these clinical applications 
will assist clinicians to use this technique judiciously. 
 
Introduction 
Coronary computed tomography angiography (CCTA) has 
become a routine imaging modality for the diagnosis of 
coronary artery disease (CAD) due to its high diagnostic 
accuracy, less invasiveness and wide availability.
1-5
 Rapid 
developments in multislice CT scanning techniques have 
enabled the CCTA to be performed in a low-dose protocol 
with radiation dose similar to that of invasive coronary 
angiography.
6-8
 Some recent studies have shown that 
radiation dose associated with CCTA can be further lowered 
to 0.1-0.4mSv, which is equivalent to that of routine chest 
radiography.
9,10
 In addition to the anatomical assessment of 
coronary lumen stenosis, CCTA allows for quantitative 
assessment of coronary plaque morphological features. This 
is clinically important as coronary lumen stenosis does not 
always translate to functional significance, as plaque 
components instead of degree of lumen stenosis play a 
critical role in predicting cardiac events and guiding patient 
management through identification of high-risk plaques. 
Furthermore, CCTA shows high diagnostic value in 
identifying myocardial ischaemic changes by providing 
functional assessment of CAD. Despite these promising 
outcomes, there are still some challenges to be resolved, 
especially the limited diagnostic value of CCTA in highly 
calcified plaques. This review article provides a 
comprehensive overview of the current developments of 






functional assessment of CCTA in CAD. Challenges of CCTA 
are discussed, and future directions are highlighted. 
 
Diagnostic value of CCTA in CAD 
CCTA has been confirmed as a reliable imaging modality in 
the diagnosis of CAD with high diagnostic accuracy. It is well 
known that the diagnostic performance of CCTA has been 
significantly improved from early generation of 4-slice CT to 
64- and post 64-slice CT. This is mainly due to the improved 
spatial and temporal resolution of multi-slice CT scanners, 
which enable detection of coronary artery and its side 
branches with high resolution: isotropic spatial resolution of 
0.4x0.4x0.4mm
3
, and temporal resolution of up to 75ms. 
The spatial resolution of current CCTA imaging technique is 
close to that of invasive coronary angiography (ICA), which 
is 0.2mm.
11
 The newly introduced high-definition CT scanner 
with substantially improved in-plane spatial resolution of 
0.23mm further improved diagnostic value of CCTA.
12
 
Pontone et al. compared the diagnostic value of high spatial 
resolution (0.23mm) with standard spatial resolution 
(0.625mm) CCTA in patients at high risk for CAD by using ICA 
as the reference method.
13
 Their results showed that overall 
agreement between CCTA and ICA was significantly 
improved in the analysis of calcified coronary plaques for 
high resolution CCTA when compared to the standard CCTA. 
The temporal resolution of current multi-slice CT scanners is 
still inferior to that of ICA, which is 10-20ms.
11
 Hence, heart 
rate control is still necessary in most of the patients to 
ensure acquisition of cardiac CT images with acceptable 
diagnostic quality. 
 
Currently, 64-slice CT has become a widely available 
technique in most of the public hospitals and private 
practices, while 128-, 256- and 320-slice CT scanners are 
also increasingly used in many clinical centres. Table 1 
shows the diagnostic value of CCTA in CAD, according to 
several systematic reviews and meta-analyses of diagnostic 
value of CCTA with use of 64-slice and 320-slice scanners.
14-
22
 As shown in Table 1, CCTA has high diagnostic sensitivity 
of more than 93 per cent and specificity of more than 86 per 
cent at per-patient assessment. It is well-known that CCTA 
has a very high negative predictive value (>95 per cent), 
thus it can be used as a gatekeeper to reliably exclude 
patients with suspected CAD. 
 
Quantitative assessment of coronary plaques by 
CCTA 
It has become well established that plaque composition is a 
key determinant of plaque stability.
23 
Progressive increasing 
worldwide use of CCTA has demonstrated that CCTA has the 
potential to revolutionise how patients are risk-stratified by 
identifying rupture-prone, non-calcified or predominant 
non-calcified coronary plaques accurately and reliably. As 
our understanding of plaque histology has improved, there 
has been an increasing interest in the ability of CCTA to 
identify particularly the high-risk or vulnerable plaques.
24,25
 
According to the SCCT (Society of Cardiovascular Computed 
Tomography) criteria of subdividing plaques into calcified, 
predominant calcified, non-calcified, predominant non-
calcified and partially calcified types, CCTA shows excellent 
inter and intra-observer agreement, and high capability to 
quantify and distinguish plaque types.
26-30 
Intravascular ultrasound (IVUS) is the gold standard for 
characterisation of coronary plaque composition. However, 
it is an invasive procedure which is not commonly 
performed in routine clinical practice and thus may be 
limited to research studies. CCTA as a less-invasive imaging 
modality has been reported to have comparable diagnostic 
value with IVUS in the assessment of plaque features. 
Studies based on head to head comparison between CCTA 
and IVUS reported the high diagnostic accuracy of CCTA 
with good correlation with IVUS for quantitative assessment 
of coronary plaques.
31,32
 The ATLANTA (Assessment of 
Tissue Characteristics, Lesion Morphology, and 
Hemodynamics by Angiography With Fractional Flow 
Reserve, Intravascular Ultrasound and Virtual Histology, and 
Non-invasive Computed Tomography in Atherosclerotic 
Plaques) study was a prospective, single-centre study 
comparing CCTA with IVUS/VH (virtual histology) in 50 
patients who underwent ICA examinations.
33
 Results 
showed a significant correlation between CCTA and 
IVUS/VH for quantitative assessment of plaque geometric, 
compositional, lumen area and vessel area measurements. 
A large retrospective study by Motoyama et al. has shown 
the promising role of CCTA plaque characterisation for 
predicting acute cardiac events in more than 1000 patients 
with suspected or known CAD with a mean follow-up of 27 
months. Researchers found that plaques with positive 
vascular remodelling and containing large areas of low 
attenuation are associated with a higher risk of acute 
coronary syndrome when compared with patients without 
these characteristics (22.2 per cent versus 0.5 per cent).
27
 
In their meta-analysis of 17 articles comparing CCTA with 
IVUS with regard to the diagnostic accuracy of CT in 
detecting coronary plaques, Gao et al. observed a good 
weighted sensitivity of 92 per cent and specificity of 93 per 
cent for CCTA in the detection of any type of coronary 
plaque as compared with IVUS, and a good positive and 
negative predictive value (>84 per cent) for diagnosis of any 






suggested that CCTA could serve as a non-invasive alterative 
to IVUS for detecting coronary plaques.
34
 This is confirmed 
by another meta-analysis comparing CCTA with IVUS for 
quantitative assessment of coronary plaques.
35
 Results 
showed that CCTA is accurate for the quantification of 
coronary plaques with mean sensitivity and specificity being 
93 per cent and 92 per cent to detect any plaque when 
compared to IVUS. Our experience of using 3D virtual 
intravascular endoscopy (VIE) for visualisation of coronary 
plaques has demonstrated the potential value of this novel 
technique for plaque characterisation and intraluminal 
appearances
36,37
 (Figure 1), although further studies should 
be conducted to correlate VIE findings with IVUS analysis. 
The reader is referred to some excellent reviewing articles 
on the CCTA in coronary plaque quantification.
37-40
 
Functional assessment of CCTA in CAD  
It is well known that anatomical coronary stenosis by CCTA 
is not necessarily associated with functional significance.
41
 
Therefore, detection of myocardial ischaemic changes 
caused by coronary plaques is more important than 
anatomical assessment of lumen stenosis since patients 
with decreased myocardial perfusion will benefit from 
revascularisation, thus, reducing adverse cardiac events. 
Myocardial CT perfusion imaging has been increasingly used 
in clinical practice with promising results reported based on 
single centre and multicentre experiences.
42-46
 Furthermore, 
improvement of the diagnostic value of myocardial CT 
perfusion imaging has been achieved by a combination of 
CCTA and myocardial CT perfusion for detection of 
myocardial ischemia.
46,47
 George et al. in their prospective, 
multicentre study comprising 381 patients from 16 centres 
demonstrated the high diagnostic value of myocardial CT 
perfusion imaging when compared with single photon 




On per-patient and per-vessel analysis, the sensitivity of 
myocardial CT perfusion imaging was significantly higher 
than that of SPECT, which was 88 per cent and 78 per cent, 
62 per cent and 54 per cent (p<0.05), respectively. The 
specificity of SPECT imaging was significantly higher than 
that of CT perfusion imaging, which was 67 per cent and 81 
per cent, 55 per cent and 62 per cent at per-patient and 
vessel analysis (p<0.05), respectively. The area under the 
receiver operating characteristic curve (AUC) for myocardial 
CT perfusion imaging was significantly higher than that for 
SPECT imaging at per-patient and per-vessel analysis, with 
corresponding values being 0.78 and 0.74, 0.69 and 0.69 
(p<0.05), respectively. Despite these promising reports, 
SPECT, as the reference method for functional assessment 
of coronary stenosis is regarded as the first line diagnostic 
test for the diagnosis and prognosis of patients with CAD as 
there is insufficient evidence to recommend CCTA as the 
first line test.
48,49
 Table 2 compares the characteristics 
between myocardial perfusion SPECT and myocardial CT 
perfusion imaging in the diagnostic evaluation of CAD. 
Recently, investigation of diagnostic performance of non-
invasive fractional flow reserve (FFR) derived from CCTA 
(FFRCT) has attracted a lot of interest. Computation of FFRCT 
is performed by computational fluid dynamics (CFD) 
modelling after segmentation of coronary arteries and left 
ventricular myocardium. Calculation of the FFRCT ratio is 
acquired by dividing the mean pressure distal to the 
coronary stenosis by the mean aortic pressure, and this can 
be measured during CFD simulations. An FFR of ≤0.80 is 
currently used as a cut off value to determine hemodynamic 
coronary stenosis responsible for myocardial ischemia 
(Figures 2 and 3).
50,51
 
Clinical validation of FFRCT is based on a direct comparison 
to measured FFR during ICA. Currently, three multicentre 
trials are available in the literature, namely DISCOVER-FLOW 
DeFACTO and NXT trials investigating the diagnostic value of 
FFRCT in CAD.
52-54
 The reported sensitivity and specificity of 
FFRCT ranged from 86–90 per cent to 54–79 per cent, on a 
per-patient analysis, while on a per-vessel analysis, the 
sensitivity and specificity of FFRCT ranged from 84 per cent 
to 86-88 per cent, respectively. Several systematic reviews 
and meta-analyses of FFRCT in comparison with CCTA with 
invasive FFR as the reference method also supported the 
statement that FFRCT was more accurate for diagnosing 
myocardial ischemia due to coronary lesions.
55-57
 Despite 
these promising results of FFRCT in the detection of flow-
limiting coronary stenosis, more multicentre trials need to 
be performed to compare the clinical impact of FFRCT 
guided-treatment versus standard diagnostic evaluation on 
clinical outcomes, costs and quality of life in patients with 
suspected coronary artery disease. 
Challenges of CCTA and future directions  
There are some limitations with CCTA which need to be 
addressed so that its clinical efficacy will be further 
enhanced. First, although CCTA allows a comprehensive 
assessment of coronary plaques regarding lumen changes 
and plaque characterization and composition, its ability to 
differentiate vulnerable or unstable plaques from those 
which are stable is still inferior to IVUS or optical coherence 
tomography.
58-61
 Therefore, differentiation of lipid-rich 
content from fibrous content with CCTA remains challenging 
due to considerable overlap in the attenuation values of 
lipid and fibrous tissue. Second, extensive coronary artery 






diagnostic accuracy of CCTA in CAD, in particular, reducing 
the sensitivity to some extent due to high rate of false 
positive results. It has been reported that highly calcified 
plaques (high calcium in the plaques) significantly lowered 
the specificity of CCTA to between 18 per cent and 44 per 
cent if no image post-processing was implemented.
62-65
  
With use of iterative reconstruction (IR) and other image 
processing algorithms, the specificity and positive predictive 
values (PPV) were improved due to suppressing the 
blooming artefacts from high calcium scores.
66-69
 Although 
IR has been confirmed to significantly reduce radiation dose 
and improve image quality when compared to the 
conventional image reconstruction of filtered back 
projection in CCTA, most recent studies have shown the 
negative impact of IR techniques on coronary artery calcium 
scores which could change patient’s risk stratification in up 
to 31 per cent patients.
70-72 
Thus, use of image processing 
algorithms could be an effective approach for diagnostic 
assessment of calcified coronary plaques. This is confirmed 
by our recent study with specificity and positive predictive 
value significantly improved for CCTA diagnosis of calcified 
plaques when compared to the conventional approach (66 
per cent and 57 per cent vs. 33 per cent and 41 per cent for 
CCTA with and without use of image processing) (Figure 
4).
68
 Despite these improvements, the specificity is still 
moderate, and more studies are needed to further enhance 
CCTA diagnostic performance. Another approach to improve 
diagnostic performance of CCTA in calcified plaques is to use 
the high definition CT scanner with substantially improved 
in-plane spatial resolution of 0.23 mm, therefore, reducing 
beam hardening and blooming artefacts due to heavy 
calcification in coronary plaques.
12
 Pontone et al. reported 
that at a segment-based analysis, the specificity and PPV 
were 98 per cent and 91 per cent for high resolution CCTA, 
which is significantly higher than the 95 per cent and 80 per 
cent for standard CCTA (0.625 mm spatial resolution). 
Significant improvement was found with high resolution 
CCTA in the analysis of calcified plaques when compared to 
the standard CCTA,
13
 although further studies are needed to 
confirm its clinical value. 
Clinical applications of CCTA in CAD have undergone a 
paradigm shift from test performance to assessment of end 
clinical outcomes. This is represented by some randomised 
controlled trials available in the recent literature, including 
FACTOR-64 Randomized Clinical Trial, PROMISE Clinical Trial, 
PLATFORM Clinical Trial and SCOT-HEART trial.
73-76
 Table 3 
summarises key findings of these four multicentre trials. As 
shown in the table, clinical value of CCTA is controversial as 
FACTOR-64 and PROMISE trials concluded that CCTA did not 
improve clinical outcomes as compared with functional 
testing or did not reduce all-cause mortality. While in the 
SCOT-HEART trial, CCTA was found to change treatment 
strategy which was associated with reduction in fatal and 
non-fatal myocardial infarction. According to the PLATFORM 
Trial, authors concluded that use of CCTA/FFRCT can be more 
effectively triage patients than the use care approach for 
invasive procedures since ICA was cancelled in 61 per cent 




Summary and conclusion 
Coronary CT angiography has developed as reliable less-
invasive imaging modality in the diagnosis of coronary 
artery disease. Tremendous progress has taken place over 
the last decades in cardiac CT imaging, owing to the 
evolution of CT scanning technology, which allows coronary 
CT angiography to serve as a potential alternative to 
invasive coronary angiography. In addition to anatomical 
assessment of coronary lumen stenosis and quantification 
of coronary plaques, functional evaluation of significance of 
coronary stenosis is also improving which is manifested by 
promising results of myocardial CT perfusion imaging. 
Coronary CT angiography-derived haemodynamic studies 
and FFRCT shows improved clinical outcomes in the 
diagnostic evaluation of patient-specific lesions. Multicentre 
trials have confirmed the clinical value of coronary CT 
angiography for reduction of cardiac mortality and 
improvement of patient outcomes, although more studies 
based on long-term follow-up are required to further 
validate its clinical applications. With more research being 
conducted using advanced cardiac CT imaging techniques, 
there is no doubt that coronary CT angiography continues to 
play an important role in the early detection and diagnosis 
of coronary artery disease and prevention of major adverse 
cardiac events through improving treatment strategy. 
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Table 1: Diagnostic value of coronary CT angiography in coronary artery disease according to systematic reviews and 
meta-analyses 
 
Type of CT 
scan 
First author 
No. of articles in 
the analysis 
Patient-based 
sensitivity (95% CI) 
Patient-based 






 27 studies 97.5% (96–99) 91% (87.5–94) 
Stein et al.
15





28 studies 99% (97–99) 89% (83–94) 
Sun et al.
17
 15 studies 97% (94–99) 88% (79–97) 
Guo et al.
18











 7 studies 95.4% (88.8–98.2) 94.7% (89.1–97.5) 
Li et al.
21
 10 studies 93% (91–95) 86% (82–89) 
Sun and Lin
22












Characteristics Myocardial CT perfusion imaging Myocardial perfusion SPECT 
Diagnostic accuracy  Yes Yes 
Prognostic value Yes Yes 
Impact on patient management Uncertain Yes 
Assessment of response to therapy Uncertain Yes 
Contribution to better outcomes Uncertain Yes 
Widespread availability Yes Yes 
Applicable in a wide spectrum of patients No Yes 
Low radiation dose to patients Yes Yes 
Cost-effectiveness Yes Yes 
 
Table 3: Summary of four multi-centre clinical trials with regard to coronary CT angiography in coronary artery 
disease 
 





900 patients with type 1 or 2 diabetes 
without symptoms of CAD from 45 clinics 
and practices were randomly assigned to 
CAD screening with CCTA (n=452) or 
standard diabetic care (n=448). The mean 
follow-up for both groups was 4.0 years. 
The primary outcome was all cause 
mortality with secondary outcome being 
ischemic adverse cardiovascular events. 
No significant differences were found between the 
CCTA and control groups in terms of primary event 
rates (6.2% vs. 7.6%, p=0.38) and second end 
points of cardiovascular events (4.4% vs. 3.8%, 
p=0.68). Results showed that CCTA did not offer 
advantage in reducing heart and coronary artery 
disease outcomes, thus, it is not recommended as 





10,003 symptomatic patients from 193 
clinical sites were assigned to anatomical 
testing with use of CCTA (n=4,996) or 
functional testing (n=5,007). The primary 
endpoint was a composite of major 
adverse cardiac events, while secondary 
endpoints included invasive cardiac 
catheterization that did not show 
obstructive CAD and cumulative radiation 
exposure. The median follow-up was 25 
months. 
CCTA did not reduce the incidence of the cardiac 
events when compared with functional testing 
(3.3% vs. 3.0%, p=0.75). CCTA was associated with 
fewer cardiac catheterization showing no 
obstructive CAD as compared with functional 
testing (3.4% vs. 4.3%, p=0.02). At 12 months’ 
follow-up, the risk of death or non-fatal myocardial 
infarction was significantly lower in CCTA group 
than in the functional testing group (p=0.049). 
Overall radiation dose was significantly higher in 
CCTA group than in the functional test group 
(12.0mSv vs. 10.1mSv, p<0.001). Over a mean 
follow-up of 2 years, CCTA as an initial strategy 
was not associated with better clinical outcomes 





584 patients with recent onset chest pain 
from 11 clinical sites were assigned to 
undergo either the planned usual care 
testing (n=287) or CCTA/FFRCT testing 
(n=297). The 90-day follow-up visits were 
reported in this study to determine the 
cardiac event rates with primary endpoint 
being rate of invasive coronary 
angiography and secondary endpoints of 
Non-obstructive CAD was found at invasive 
coronary angiography in 12% of the patients in the 
CCTA/FFRCT group, which is significantly lower than 
that observed in the usual care group (73%) 
(p<0.0001). No significant differences were found 
in cardiac events between these two groups 
(p=0.95). The use of CCTA/FFRCT can be more 
effectively triage patients than the use care 






adverse cardiovascular events. coronary angiography was cancelled in 61% 





4,146 patients with suspected angina from 
12 cardiology clinics were randomly 
assigned to receive standard care plus 
CCTA (n=2,073) or standard care alone 
(n=2,073). The mean follow-up for both 
groups was 1.4 years. The primary 
endpoint was percentage of patients 
diagnosed with angina secondary to CAD at 
six weeks, and long-term outcomes were 
adverse cardiac events.  
CCTA increased certainty and frequency of the 
diagnosis of CAD at six weeks when compared with 
standard care (p<0.0001). This was translated into 
increased certainty but no effect on frequency of 
diagnosis of angina due to CAD for primary 
endpoints. CCTA was associated with 38% 
reduction in cardiac death and non-fatal 
myocardial infarction. Addition of CCTA to clinical 
care changed the treatment strategies. 
 
Figure 1: 3D virtual intravascular endoscopy of coronary plaques 
 
 
Virtual intravascular endoscopy (VIE) visualisation of mixed and calcified plaques in a 75-year-old man with coronary 
artery disease. A Curved planar reformation shows mixed plaque (short arrow) and calcified plaque (long arrows) in the 
proximal segment of left anterior descending coronary artery (LAD). B Close VIE view of the mixed plaque. C VIE view of 











Figure 2: Fractional flow reserve (FFR) derived from CT angiography (FFRCT) results for 66-year-old man with multi-
vessel coronary artery disease but no lesion-specific ischemia 
 
 
(A) Coronary computed tomography angiography (CCTA) demonstrating stenosis in the left anterior descending 
coronary artery (LAD). (B) FFRCT demonstrates no ischemia in the LAD, with a computed value of 0.91. (C) Invasive 
coronary angiography (ICA) with FFR also demonstrates no ischemia in the LAD, with a measured value of 0.89. (D) 
CCTA demonstrating stenosis in the left circumflex coronary (LCx) artery. (E) FFRCT demonstrates no ischemia in the LCx, 
with a computed value of 0.91. (F) ICA with FFR also demonstrates no ischemia in the LCx, with a measured value of 









Figure 3: FFRCT results for 66-year-old man with multi-vessel CAD and lesion-specific ischemia 
 
 
(A) Coronary CT Angiography (CCTA) demonstrating stenosis in the left anterior descending coronary artery (LAD). (B) 
FFRCT demonstrates ischemia in the LAD, with a computed value of 0.64. (C) Invasive coronary angiography (ICA) with 
FFR also demonstrates ischemia in the LAD, with a measured value of 0.72. (D) CCTA demonstrating stenosis in the left 
circumflex (LCx). (E) FFRCT demonstrates ischemia in the LCx, with a computed value of 0.61. (F) ICA with FFR also 










Figure 4: Use of image post-processing algorithms in CCTA for visualisation of calcified coronary plaques 
 
 
Areas under the curve (AUCs) by receiver-operating characteristic curve analysis demonstrate significant improvements 
in diagnostic performance of coronary CT angiography (CCTA) with use of image sharpen (CCTA_S) when compared to 
the original (CCTA_O) and smooth algorithms (CCTA_OS) in the detection of significant coronary stenosis at the left 
anterior descending coronary artery. Reprinted under the terms of open access article from reference.
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